Livdelzi Disease Interactions
There are 3 disease interactions with Livdelzi (seladelpar).
Seladelpar (applies to Livdelzi) biliary obstruction
Moderate Potential Hazard, Moderate plausibility.
Seladelpar should be avoided in patients with complete biliary obstruction. If biliary obstruction is suspected this drug should be interrupted and treatment started as clinically indicated.
Seladelpar (applies to Livdelzi) dialysis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: hemodialysis
The use of seladelpar in patients with end-stage renal disease undergoing dialysis has not been studied.
Seladelpar (applies to Livdelzi) liver disease
Moderate Potential Hazard, Moderate plausibility.
The safety and efficacy of seladelpar in patients with decompensated cirrhosis have not been established and its use is not recommended in patients who have or develop decompensated cirrhosis (e.g., ascites, variceal bleeding, hepatic encephalopathy). No dose adjustment is recommended in patients with mild liver dysfunction, but discontinuation of treatment should be considered in any patients progressing to moderate or severe liver dysfunction (Child-Pugh B or C).
Switch to professional interaction data
Livdelzi drug interactions
There are 150 drug interactions with Livdelzi (seladelpar).
Report options
More about Livdelzi (seladelpar)
- Livdelzi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- FDA approval history
- Drug class: miscellaneous metabolic agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Actigall
Actigall is used for gallbladder disease, primary biliary cholangitis
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Ocaliva
Ocaliva may be used to treat primary biliary cholangitis (PBC) in adults without cirrhosis or with ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Urso Forte
Urso Forte is used for gallbladder disease, primary biliary cholangitis
Reltone
Reltone is used for gallbladder disease, primary biliary cholangitis
Obeticholic acid
Obeticholic acid (brand name Ocaliva) may be used to treat primary biliary cholangitis (PBC) in ...
Ursodiol
Ursodiol information from Drugs.com, includes Ursodiol side effects, interactions and indications.
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
